Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TMPRSS2 | O15393 | 1/20 | 0.38 |
| ▸ | RIPK1 | Q13546 | 4/20 | 0.32 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Remidevir SCHEMBL23959877 | 1.00 | TMPRSS2 (0.38) | TMPRSS2RIPK1PIK3CD | |
| Remidevir SCHEMBL30996064 | 1.00 | TMPRSS2 (0.38) | TMPRSS2RIPK1PIK3CD | |
| Remidevir SCHEMBL25365610 | 0.99 | TMPRSS2 (0.38) | TMPRSS2RIPK1 | |
| SCHEMBL24312546 | 0.94 | TMPRSS2 (0.36) | TMPRSS2RIPK1 | |
| SCHEMBL27216324 | 0.94 | TMPRSS2 (0.36) | TMPRSS2RIPK1 | |
| SCHEMBL25252587 | 0.94 | TMPRSS2 (0.36) | TMPRSS2RIPK1 | |
| SCHEMBL26206939 | 0.94 | TMPRSS2 (0.37) | TMPRSS2RIPK1 | |
| SCHEMBL25380699 | 0.93 | TMPRSS2 (0.36) | TMPRSS2RIPK1 | |
| SCHEMBL23960031 | 0.92 | TMPRSS2 (0.42) | TMPRSS2RIPK1 | |
| SCHEMBL23960033 | 0.92 | TMPRSS2 (0.43) | TMPRSS2RIPK1PIK3CD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4234557-A1 | SALT OF NUCLEOSIDE ANALOG AND CRYSTAL FORM THEREOF, PHARMACEUTICAL COMPOSITION AND USE | Vigonvita Life Sciences Co., Ltd. (CN) | 2023-08-30 | — | — | EP | disclosed |